SEC Form 4 · accession 0001193125-26-286434
Jade Biosciences, Inc. · JBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Eisner
Director
Period of report
Jun 25, 2026
Accepted (ET)
Jun 26, 2026 · 9:20 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001798749
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $21.81 | Jun 25, 2026 | A | 47,675 | A | — | Jun 24, 2036 | Common Stock | 47,675 | 47,675 | D |
Explanation of responses
- F11/36th of the total number of shares of common stock subject to the option vest monthly following the date of grant, subject to the Reporting Person's continued service to the Issuer through each vesting date.